Clinical evaluation of free PSA/total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer

European Journal of Cancer Part A

Volumn 33, Issue 8, 1997, Pages 1226-1229

  Filella, X ^a   Alcover, J ^a   Molina, R ^a   Rodriguez A ^a   Carretero, P ^a   Ballesta, A M ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Free PSA; Prostate cancer; PSA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; ARTICLE; CANCER CYTODIAGNOSIS; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNORADIOMETRIC ASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; TISSUE DISTRIBUTION; TRANSURETHRAL RESECTION;

DIAGNOSIS, DIFFERENTIAL; EVALUATION STUDIES; HUMANS; MALE; NEOPLASM PROTEINS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 0343742616     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(97)00081-6     Document Type: Article

References (18)

1. Wang MC, Valenzuela LA, Murphy GP, Chu TM. Purification of a human prostate specific antigen. Invest Urol 1979, 17, 159-163.
2. Ambruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application. Clin Chem 1993, 39, 181-195.
3. Christensson A, Laurell CB, Lilja H. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors. Eur J Biochem 1990, 194, 755-763.
4. Stenman UH, Leinonen J, Alfthan H, Rannikko S, Tuhkanen K, Alfthan O. A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer: assay of the complex improves clinical sensitivity for cancer. Cancer Res 1991, 51, 222-226.
5. Lilja H, Christensson A, Dahlén U, et al. Prostate-specific antigen in serum occurs predominantly in complex with alpha-1-antichymotrypsin. Clin Chem 1991, 37, 1618-1625.
6. Van Lersel MP, Witjes WPJ, Thomas CMG, Segers MFG, Oosterhof GON, Debruyne FMJ. Review of the simultaneous determination of total prostate-specific antigen and free prostate-specific antigen. The Prostate 1996, 7, 48-57.
7. Morote J, Ruibal A, Palou J. Evaluation of specific antigen and prostatic acid phosphatase specificity. Study of false values. Int J Biol Markers 1986, 1, 141-146.
8. Ercole CJ, Lange PH, Mathisen M, Chiou RK, Reddy PK, Vessella RL. Prostate specific antigen and prostate acid phosphatase in the monitoring and staging of patients with prostatic cancer. J Urol 1987, 138, 1181-1184.
9. Filella X, Molina R, Jo J, Umbert B, Bedini JL, Ballesta AM. Clinical usefulness of prostate specific antigen and prostatic acid phosphatase. Tumor Biol 1990, 11, 289-295.
10. Filella X, Molina R, Ballesta AM, et al. Value of PSA (prostate-specific antigen) in the detection of prostate cancer in patients with urological symptoms. Results of a multicentre study. Eur J Cancer 1996, 32A, 1125-1128.
11. Benson MC, Whang IS, Pantuck A, et al. Prostate specific antigen density: a means of distinguishing benign prostatic hypertrophy and prostate cancer. J Urol 1992, 147, 815-816.
12. Carter HB, Pearson JD, Metter EJ, et al. Longitudinal evaluation of prostate-specific antigen levels in men with and without prostate disease. JAMA 1992, 267, 2215-2220.
13. Christensson A, Björk T, Nilsson O, et al. Serum prostate specific antigen complexed to alfa-1-antichymotrypsin as an indicator of prostate cancer. J Urol 1993, 150, 100-105.
14. Leinonen J, Lövgren T, Vornanen T, Stenman UH. Doublelabel time resolved immunofluorometric assay of prostate-specific antigen and its complex with alpha-1-antichymotrypsin. Clin Chem 1993, 39, 2098-2103.
15. Bostwick DG, Cooner WH, Denis L, Jones GW, Scardino PT, Murphy GP. The association of benign prostatic hyperplasia and cancer of the prostate. Cancer 1992, 70, 291-301.
16. Alcover J, Filella X, Barranco MA, Molina R, Ballesta AM, Carretero P. False positive values of PAP and PSA in complicated and non-complicated benign prostatic hypertrophy. Arch Int Urol 1993, 65, 491-494.
17. Filella X, Alcover J, Molina R, Carrere W, Carretero P, Ballesta AM. Usefulness of prostate-specific antigen density as a diagnostic test of prostate cancer. Tumor Biol 1996, 17, 20-26.
18. Catalona WJ, Richie JP, Ahmann FR, et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 1994, 151, 1283-1290.